Biotech firm Cassava Sciences' CEO steps down
July 17 (Reuters) - Cassava Sciences SAVA.O said on Wednesday CEO Remi Barbier has resigned and the biotech firm named Richard Barry as interim chief executive. (Reporting by Mariam Sunny in Bengaluru; Editing by Shounak Dasgupta) ((Mariam.ESunny@thomsonreuters.com))
Recent news on Filana Therapeutics
See all newsCassava Sciences says US DOJ has closed investigation into company (updated)
Cassava Sciences rises after US DOJ closes probe into company
Cassava Sciences says US DOJ has closed investigation into company
Brief: Cassava Announces Agreement To Settle Securities Class Action Litigation
Brief: Cassava Sciences Inc - On Dec 15, FDA Places Full Clinical Hold On Cassava's Trial - SEC Filing